These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


399 related items for PubMed ID: 8863083

  • 1. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z, Biro FM, Kollar LM, Rauh JL.
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [Abstract] [Full Text] [Related]

  • 2. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z, Biro FM, Kollar LM.
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 4. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 5. Contraception in the adolescent patient.
    Tafelski T, Boehm KE.
    Prim Care; 1995 Mar; 22(1):145-59. PubMed ID: 7777635
    [Abstract] [Full Text] [Related]

  • 6. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 9. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
    Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D.
    J Pediatr Adolesc Gynecol; 2005 Apr; 18(2):85-90. PubMed ID: 15897103
    [Abstract] [Full Text] [Related]

  • 10. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
    American Health Consultants.
    Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
    [Abstract] [Full Text] [Related]

  • 11. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS, Dennerstein GJ.
    Med J Aust; 1994 May 02; 160(9):553-6. PubMed ID: 8164553
    [Abstract] [Full Text] [Related]

  • 12. The use of Norplant and Depo Provera in adolescents.
    Ammerman SD.
    J Adolesc Health; 1995 May 02; 16(5):343-6. PubMed ID: 7662681
    [Abstract] [Full Text] [Related]

  • 13. Introducing more contraceptive methods in Jordan.
    Gallagher M.
    AVSC News; 1998 May 02; 36(1):3, 8. PubMed ID: 12321883
    [Abstract] [Full Text] [Related]

  • 14. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, Nichols D, Katz K, Jessencky K, Liku J.
    East Afr Med J; 1996 Dec 02; 73(12):786-94. PubMed ID: 9103686
    [Abstract] [Full Text] [Related]

  • 15. Teens and Depo-Provera: a good match?
    Contracept Technol Update; 1995 Jul 02; 16(7):86-8. PubMed ID: 12346507
    [Abstract] [Full Text] [Related]

  • 16. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct 02; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 17. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.
    Polaneczky M, Slap G, Forke C, Rappaport A, Sondheimer S.
    N Engl J Med; 1994 Nov 03; 331(18):1201-6. PubMed ID: 7935659
    [Abstract] [Full Text] [Related]

  • 18. Determinants of early implant discontinuation among low-income women.
    Kalmuss D, Davidson AR, Cushman LF, Heartwell S, Rulin M.
    Fam Plann Perspect; 1996 Nov 03; 28(6):256-60. PubMed ID: 8959415
    [Abstract] [Full Text] [Related]

  • 19. Ask the experts: progestin-only contraceptives.
    Hatcher RA, Schnare S.
    Contracept Technol Update; 1993 Jul 03; 14(7):114-5. PubMed ID: 12286999
    [Abstract] [Full Text] [Related]

  • 20. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya.
    Ruminjo JK, Sekadde-Kigondu CB, Karanja JG, Rivera R, Nasution M, Nutley T.
    Contraception; 2005 Aug 03; 72(2):138-45. PubMed ID: 16022854
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.